Cargando…

A comprehensive map of human glucokinase variant activity

BACKGROUND: Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic hypoglycemia or hyperglycemia associated with GCK-maturity-onset diabetes of the young (GCK-MODY), collectively affecting up to 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gersing, Sarah, Cagiada, Matteo, Gebbia, Marinella, Gjesing, Anette P., Coté, Atina G., Seesankar, Gireesh, Li, Roujia, Tabet, Daniel, Weile, Jochen, Stein, Amelie, Gloyn, Anna L., Hansen, Torben, Roth, Frederick P., Lindorff-Larsen, Kresten, Hartmann-Petersen, Rasmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131484/
https://www.ncbi.nlm.nih.gov/pubmed/37101203
http://dx.doi.org/10.1186/s13059-023-02935-8
_version_ 1785031188075773952
author Gersing, Sarah
Cagiada, Matteo
Gebbia, Marinella
Gjesing, Anette P.
Coté, Atina G.
Seesankar, Gireesh
Li, Roujia
Tabet, Daniel
Weile, Jochen
Stein, Amelie
Gloyn, Anna L.
Hansen, Torben
Roth, Frederick P.
Lindorff-Larsen, Kresten
Hartmann-Petersen, Rasmus
author_facet Gersing, Sarah
Cagiada, Matteo
Gebbia, Marinella
Gjesing, Anette P.
Coté, Atina G.
Seesankar, Gireesh
Li, Roujia
Tabet, Daniel
Weile, Jochen
Stein, Amelie
Gloyn, Anna L.
Hansen, Torben
Roth, Frederick P.
Lindorff-Larsen, Kresten
Hartmann-Petersen, Rasmus
author_sort Gersing, Sarah
collection PubMed
description BACKGROUND: Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic hypoglycemia or hyperglycemia associated with GCK-maturity-onset diabetes of the young (GCK-MODY), collectively affecting up to 10 million people worldwide. Patients with GCK-MODY are frequently misdiagnosed and treated unnecessarily. Genetic testing can prevent this but is hampered by the challenge of interpreting novel missense variants. RESULT: Here, we exploit a multiplexed yeast complementation assay to measure both hyper- and hypoactive GCK variation, capturing 97% of all possible missense and nonsense variants. Activity scores correlate with in vitro catalytic efficiency, fasting glucose levels in carriers of GCK variants and with evolutionary conservation. Hypoactive variants are concentrated at buried positions, near the active site, and at a region of known importance for GCK conformational dynamics. Some hyperactive variants shift the conformational equilibrium towards the active state through a relative destabilization of the inactive conformation. CONCLUSION: Our comprehensive assessment of GCK variant activity promises to facilitate variant interpretation and diagnosis, expand our mechanistic understanding of hyperactive variants, and inform development of therapeutics targeting GCK. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-02935-8.
format Online
Article
Text
id pubmed-10131484
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101314842023-04-27 A comprehensive map of human glucokinase variant activity Gersing, Sarah Cagiada, Matteo Gebbia, Marinella Gjesing, Anette P. Coté, Atina G. Seesankar, Gireesh Li, Roujia Tabet, Daniel Weile, Jochen Stein, Amelie Gloyn, Anna L. Hansen, Torben Roth, Frederick P. Lindorff-Larsen, Kresten Hartmann-Petersen, Rasmus Genome Biol Research BACKGROUND: Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic hypoglycemia or hyperglycemia associated with GCK-maturity-onset diabetes of the young (GCK-MODY), collectively affecting up to 10 million people worldwide. Patients with GCK-MODY are frequently misdiagnosed and treated unnecessarily. Genetic testing can prevent this but is hampered by the challenge of interpreting novel missense variants. RESULT: Here, we exploit a multiplexed yeast complementation assay to measure both hyper- and hypoactive GCK variation, capturing 97% of all possible missense and nonsense variants. Activity scores correlate with in vitro catalytic efficiency, fasting glucose levels in carriers of GCK variants and with evolutionary conservation. Hypoactive variants are concentrated at buried positions, near the active site, and at a region of known importance for GCK conformational dynamics. Some hyperactive variants shift the conformational equilibrium towards the active state through a relative destabilization of the inactive conformation. CONCLUSION: Our comprehensive assessment of GCK variant activity promises to facilitate variant interpretation and diagnosis, expand our mechanistic understanding of hyperactive variants, and inform development of therapeutics targeting GCK. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-02935-8. BioMed Central 2023-04-26 /pmc/articles/PMC10131484/ /pubmed/37101203 http://dx.doi.org/10.1186/s13059-023-02935-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gersing, Sarah
Cagiada, Matteo
Gebbia, Marinella
Gjesing, Anette P.
Coté, Atina G.
Seesankar, Gireesh
Li, Roujia
Tabet, Daniel
Weile, Jochen
Stein, Amelie
Gloyn, Anna L.
Hansen, Torben
Roth, Frederick P.
Lindorff-Larsen, Kresten
Hartmann-Petersen, Rasmus
A comprehensive map of human glucokinase variant activity
title A comprehensive map of human glucokinase variant activity
title_full A comprehensive map of human glucokinase variant activity
title_fullStr A comprehensive map of human glucokinase variant activity
title_full_unstemmed A comprehensive map of human glucokinase variant activity
title_short A comprehensive map of human glucokinase variant activity
title_sort comprehensive map of human glucokinase variant activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131484/
https://www.ncbi.nlm.nih.gov/pubmed/37101203
http://dx.doi.org/10.1186/s13059-023-02935-8
work_keys_str_mv AT gersingsarah acomprehensivemapofhumanglucokinasevariantactivity
AT cagiadamatteo acomprehensivemapofhumanglucokinasevariantactivity
AT gebbiamarinella acomprehensivemapofhumanglucokinasevariantactivity
AT gjesinganettep acomprehensivemapofhumanglucokinasevariantactivity
AT coteatinag acomprehensivemapofhumanglucokinasevariantactivity
AT seesankargireesh acomprehensivemapofhumanglucokinasevariantactivity
AT liroujia acomprehensivemapofhumanglucokinasevariantactivity
AT tabetdaniel acomprehensivemapofhumanglucokinasevariantactivity
AT weilejochen acomprehensivemapofhumanglucokinasevariantactivity
AT steinamelie acomprehensivemapofhumanglucokinasevariantactivity
AT gloynannal acomprehensivemapofhumanglucokinasevariantactivity
AT hansentorben acomprehensivemapofhumanglucokinasevariantactivity
AT rothfrederickp acomprehensivemapofhumanglucokinasevariantactivity
AT lindorfflarsenkresten acomprehensivemapofhumanglucokinasevariantactivity
AT hartmannpetersenrasmus acomprehensivemapofhumanglucokinasevariantactivity
AT gersingsarah comprehensivemapofhumanglucokinasevariantactivity
AT cagiadamatteo comprehensivemapofhumanglucokinasevariantactivity
AT gebbiamarinella comprehensivemapofhumanglucokinasevariantactivity
AT gjesinganettep comprehensivemapofhumanglucokinasevariantactivity
AT coteatinag comprehensivemapofhumanglucokinasevariantactivity
AT seesankargireesh comprehensivemapofhumanglucokinasevariantactivity
AT liroujia comprehensivemapofhumanglucokinasevariantactivity
AT tabetdaniel comprehensivemapofhumanglucokinasevariantactivity
AT weilejochen comprehensivemapofhumanglucokinasevariantactivity
AT steinamelie comprehensivemapofhumanglucokinasevariantactivity
AT gloynannal comprehensivemapofhumanglucokinasevariantactivity
AT hansentorben comprehensivemapofhumanglucokinasevariantactivity
AT rothfrederickp comprehensivemapofhumanglucokinasevariantactivity
AT lindorfflarsenkresten comprehensivemapofhumanglucokinasevariantactivity
AT hartmannpetersenrasmus comprehensivemapofhumanglucokinasevariantactivity